Mechanisms Involved in Cardiac Sensitization by Volatile Anesthetics: General Applicability to Halogenated Hydrocarbons?

REFERENCES

• M. H. Abraham, W. R. Lieb, and N. P. Franks. (1991). Role of hydrogen bonding in general anesthesia. J. Pharm. Sci. 80:719–724.
   PubMed Web of Science ®Google Scholar
• J. Adir, D. A. Blake, and G. M. Mergner. (1975). Pharmacokinetics of fluorocarbon 11 and 12 in dogs and humans. J. Clin. Pharmacol. 15:760–770.
   PubMed Web of Science ®Google Scholar
• A. Aguado-Matorras. (1974). Comparative study of myocardial sensitization to norepinephrine under halothane and enflurane anesthesia. Acta Anaesthesiol. Belgica 25:198–205.
   PubMedGoogle Scholar
• D. J. Alexander, E. Mortimer, G. D. Dines, S. E. Libretto, and D. N. Mallett. (1995). One-year study in dogs of the toxicity of HFA-134a by inhalation. Inhal. Toxicol. 7:1153–1162.
   Web of Science ®Google Scholar
• Y. M. Amin, E. B. Thompson, and W. L. Chiou. (1979). Fluorocarbon aerosol propellants XII: Correlation of blood level of trichloromonofluoromethane to cardiovascular and respiratory responses in anesthetized dogs. J. Pharm. Sci. 68:160–163.
   PubMed Web of Science ®Google Scholar
• J. Angerer, B. Schroeder, and R. Heinrich. (1985). Exposure to fluorotrichloromethane (R-11). Int. Arch. Occup. Environ. Health 56:67–72.
   PubMed Web of Science ®Google Scholar
• Z. Annau. (1981). The neurobehavioral toxicity of trichloroethylene. Neurobehav. Toxicol. Teratol. 3:417–424.
   PubMedGoogle Scholar
• B. L. Anthony, R. L. Dennison, and R. S. Aronstam. (1989). Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neurosci. Lett. 99:191–196.
   PubMedGoogle Scholar
• M. Antti-Poika, J. Heikkilä, and L. Saarinen. (1990). Cardiac arrhythmias during occupational exposure to fluorinated hydrocarbons. Br. J. Ind. Med. 47:138–140.
   PubMedGoogle Scholar
• E. P. Anyukhovsky, S. D. Guo, P. Danilo, and M. R. Rosen. (1997). Responses to norepinephrine of normal and “ischemic” canine Purkinje fibers are consistent with activation of different α1-receptor subtypes. J. Cardiovasc. Electrophysiol. 8:658–666.
   PubMedGoogle Scholar
• C. Arias, T. Gonzalez, I. Moreno, R. Caballero, E. Delpon, J. Tamargo, and C. Valenzuela. (2003). Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on hERG channels. Cardiovasc. Res. 57:660–669.
   PubMedGoogle Scholar
• T. Asai, K. Kusudo, H. Ikeda, M. Takenoshita, and K. Murase. (2002). Effect of halothane on neuronal excitation in the superficial dorsal horn of rat spinal cord slices: Evidence for a presynaptic action. Eur. J. Neurosci. 15:1278–1290.
   PubMedGoogle Scholar
• A. Astier, and F. Paraire. (1997). Fatal intoxication with 1,1-dichloro–1-fluoroethane. N. Engl. J. Med. 337:940.
   PubMedGoogle Scholar
• J. L. Atlee, and C. E. Malkinson. (1982). Potentiation by thiopental of halothane-epinephrine-induced arrhythmias in dogs. Anesthesiology 57:285–288.
   PubMedGoogle Scholar
• A. Azar, H. J. Trochimowicz, J. B. Terrill, and L. S. Mullin. (1973). Blood levels of fluorocarbon related to cardiac sensitization. Am. Ind. Hyg. Assoc. J. 34:102–109.
   PubMed Web of Science ®Google Scholar
• A. Barbuti, S. Ishii, T. Shimizu, R. B. Robinson, and S. J. Feinmark. (2002). Block of the background K+ channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. Am. J. Physiol. 282:H2024–H2030.
   Google Scholar
• M. Bass. (1970). Sudden sniffing death. J. Am. Med. Assoc. 212:2075–2079.
   PubMed Web of Science ®Google Scholar
• P. S. Beck, D. G. Clark, and D. J. Tinston. (1973). The pharmacologic actions of bromochlorodifluoromethane (BCF). Toxicol. Appl. Pharmacol. 24:20–29.
   PubMed Web of Science ®Google Scholar
• M. J. Beckstead, R. Phelan, and S. J. Mihic. (2001). Antagonism of inhalant and volatile anesthetic enhancement of glycine receptor function. J. Biol. Chem. 276:24959–24964.
   PubMedGoogle Scholar
• M. J. Beckstead, J. L. Weiner, E. I. Eger, D. H. Gong, and S. J. Mihic. (2000). Glycine and γ -aminobutyric acidA receptor function is enhanced by inhaled drugs of abuse. Mol. Pharmacol. 57:1199–1205.
   PubMed Web of Science ®Google Scholar
• G. Boachie-Ansah, K. A. Kane, and J. R. Parratt. (1989). Cardiac electrophysiological effects of isoprenaline, phenylephrine, and noradrenaline on normal and mildly “ischaemic” sheep Purkinje fibers. J. Cardiovasc. Pharmacol. 13:291–298.
   PubMedGoogle Scholar
• M. Böhm, U. Schmidt, P. Gierschik, R. H.G. Schwinger, S. Böhm, and E Erdmann. (1994). Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc− cells: Evidence for inactivation of the inhibitory G protein Giα. Mol. Pharmacol. 45:380–389.
   PubMedGoogle Scholar
• M. Böhm, U. Schmidt, R. H.G. Schwinger, S. Böhm, and E. Erdmann. (1993). Effects of halothane on β -adrenoceptors and M-cholinoceptors in human myocardium: Radioligand binding and functional studies. J. Cardiovasc. Pharmacol. 21:296–304.
   PubMedGoogle Scholar
• Z. J. Bosnjak, F. D. Supan, and N. J. Rusch. (1991). The effects of halothane, enflurane, and isoflurane on calcium current in isolated canine ventricular cells. Anesthesiology 74:340–345.
   PubMedGoogle Scholar
• T. Breindahl. (2000). Therapeutic drug monitoring of flecainide in serum using high-performance liquid chromatography and electronspray mass spectrometry. J. Chromatogr. B 746:249–254.
   PubMedGoogle Scholar
• W. J. Brock, G. M. Rusch, and H. J. Trochimowicz. (2003). Cardiac sensitization: Methodology and interpretation in risk assessment. Regul. Toxicol. Pharmacol. 38:78–90.
   PubMed Web of Science ®Google Scholar
• W. J. Brock, H. J. Trochimowicz, R. J. Millischer, C. Farr, T. Kawano, and G. M. Rusch. (1995). Acute and subchronic toxicity of 1,1-dichloro-1-fluoroethane (HCFC-141b). Food Chem. Toxicol. 33:483–490.
   PubMed Web of Science ®Google Scholar
• E. Brode, H. Müller-Peltzer, and M. Hollmann. (1988). Comparative pharmacokinetics and clinical pharmacology of propafenone enantiomers after oral administration to man. Methods Find. Exp. Clin. Pharmacol. 10:717–27.
   PubMedGoogle Scholar
• B. R. Brown, E. N. Tatum, and J. R. Crout. (1972). The effects of inhalation anesthetics on the uptake and metabolism of 1-3H-norepinephrine in guinea-pig atria. Anesthesiology 36:263–267.
   PubMedGoogle Scholar
• J. Buss, H. Neuss, Y. Bilgin, and M. Schlepper. (1985). Malignant ventricular tachyarrhythmias in association with propafenone treatment. Eur. Heart J. 6:424–428.
   PubMedGoogle Scholar
• D. S. Calkins, J. J. Degioanni, M. N. Tan, J. R. Davis, and D. L. Pierson. (1993). Human performance and physiological function during a 24-hr exposure to 1% bromotrifluoromethane (halon 1301). Fundam. Appl. Toxicol. 20:240–247.
   PubMedGoogle Scholar
• J. A. Campagna, K. W. Miller, and S. A. Forman. (2003). Mechanisms of actions of inhaled anesthetics. N. Engl. J. Med. 348:2110–2124.
   PubMed Web of Science ®Google Scholar
• M. D. Carceles, M. L. Laorden, J. Hernandez, F. S. Miralles, and M. Campos. (1990). Halothane, isoflurane and enflurane potentiate the effect of noradrenaline on ventricular automaticity in the rat heart: evidence of the involvement of both α-or β -adrenoceptors. J. Pharm. Pharmacol. 42:186–190.
   PubMedGoogle Scholar
• V. L. Carter, K. C. Back, and D. N. Farrer. (1970). The effect of bromotrifluoromethane on operant behaviour in monkeys. Toxicol. Appl. Pharmacol. 17:648–655.
   PubMed Web of Science ®Google Scholar
• X. Chen, J. S. Cordes, J. A. Bradley, Z. Q. Sun, and J. Zhou. (2006). Use of arterially perfused rabbit ventricular wedge in predicting arrhythmogenic potentials of drugs. J. Pharmacol. Toxicol. Methods 54:261–272.
   PubMedGoogle Scholar
• X. D. Chen, M. Yamakage, Y. Yamada, N. Tohse, and A. Mamiki. (2002). Inhibitory effects of volatile anesthetics on currents produced on heterologous expression of KvLQT1 and minK in Xenopus oocytes. Vasc. Pharmacol. 39:33–38.
   PubMedGoogle Scholar
• L. S. Chen, S. M. Zhou, M. C. Fishbein, and P. S. Chen. (2007). New perspectives on the role of autonomic nervous system in the genesis of arrhythmias. J. Cardiovasc. Electrophysiol. 18:123–127.
   PubMedGoogle Scholar
• J. S. Chiou, P. R. Krishna, H. Kamaya, and I. Ueda. (1992). Alcohols dehydrate lipid membranes: an infrared study on hydrogen bonding. Biochim. Biophys. Acta 1110:225–233.
   PubMed Web of Science ®Google Scholar
• Y. H. Chou, J. Wei, and C. Lin. (1991). Halothane inhibits residual fast sodium channels in human atrial muscle. Anesthesiology 75:716–717.
   PubMedGoogle Scholar
• L. D. Claborn, and M. Szabuniewicz. (1973). Prevention of chloroform and thiobarbiturate cardiac sensitization to catecholamines in dogs. Am. J. Vet. Res. 34:801–804.
   PubMedGoogle Scholar
• D. G. Clark, and D. J. Tinston. (1973). Correlation of the cardiac sensitization potential of halogenated hydrocarbons with their physicochemical properties. Br. J. Pharmacol. 49:355–357.
   PubMed Web of Science ®Google Scholar
• D. G. Clark, and D. J. Tinston. (1982). Acute inhalation toxicity of some halogenated and non-halogenated hydrocarbons. Hum. Toxicol. 1:239–247.
   PubMedGoogle Scholar
• T. J. Colatsky, C. H. Follmer, and C. F. Starmer. (1990). Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 82:2235–2242.
   PubMed Web of Science ®Google Scholar
• J. H. Coote. (2007). Landmarks in understanding the central nervous control of the cardiovascular system. Exp. Physiol. 92:3–18.
   PubMed Web of Science ®Google Scholar
• A. M. Correa. (1998). Gating kinetics of shaker K+ channels are differentially modified by general anesthetics. Am. J. Physiol. 275:C1009–C1021.
   Google Scholar
• P. F. Cranefield. (1977). Action potentials, afterpotentials, and arrhythmias. Circ. Res. 41:415–423.
   PubMedGoogle Scholar
• S. L. Cruz, R. L. Balster, and J. J. Woodward. (2000). Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Br. J. Pharmacol. 131:1303–1308.
   PubMed Web of Science ®Google Scholar
• S. Daniels, and E. B. Smith. (1993). Effects of general anaesthetics on ligand-gated ion channels. Br. J. Anaesth. 71:59–64.
   PubMedGoogle Scholar
• L. A. Davies, P. M. Hopkins, M. R. Boyett, and S. M. Harrison. (2000). Effects of halothane on the transient outward K+ current in rat ventricular myocytes. Br. J. Pharmacol. 131:223–230.
   PubMedGoogle Scholar
• W. Dekant. (1996). Toxicology of chlorofluorocarbon replacements. Environ. Health Perspect. 104 (suppl. 1):75–83.
   PubMedGoogle Scholar
• C. Delgado, J. Tamargo, and T. Tejerina. (1985). Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres. Br. J. Pharmacol. 86:765–775.
   PubMedGoogle Scholar
• E. Delpon, C. Valenzuela, O. Perez, O. Casis, and J. Tamargo. (1995). Propafenone preferentially blocks the rapidly activating component of delayed rectifier K+ current in guinea-pig ventricular myocytes: Voltage-independent and time-dependent block of the slowly activating component. Circ. Res. 76:223–235.
   PubMedGoogle Scholar
• J. E. Dildy-Mayfield, E. I. Eger, and R. A. Harris. (1996). Anesthetics produce subunit-selective actions on glutamate receptors. J. Pharmacol. Exp. Ther. 276:1058–1065.
   PubMedGoogle Scholar
• C. T. Dollery. (1973). Absorption and fate of isoproterenol and fluorocarbons inhaled from pressurized aerosols. Ann. Allergy 31:25–30.
   Google Scholar
• D. L. Downie, F. Vicente-Agullo, A. Campos-Caro, T. J. Bushell, W. R. Lieb, and N. P. Franks. (2002). Determinants of the anesthetic sensitivity of neuronal nicotinic acetylcholine receptors. J. Biol. Chem. 277:10367–10373.
   PubMedGoogle Scholar
• D. Duan, B. Fermini, and S. Nattel. (1993). Potassium channel blocking properties of propafenone in rabbit atrial myocytes. J. Pharmacol. Exp. Ther. 264:1113–1123.
   PubMedGoogle Scholar
• ECETOC. (1994). 1,1-Dichloro–1-fluoroethane (HCFC-141b). Joint Assess. Commod. Chem. 29:1–46.
   Google Scholar
• ECETOC. (1994). Pentafluoroethane (HFC-125). Joint Assess. Commod. Chem. 24:1–35.
   Google Scholar
• ECETOC. (1995). Difluoromethane (HFC-32). Joint Assess. Commod. Chem. 32:1–23.
   Google Scholar
• ECETOC. (2004). 1-Chloro-1,2,2,2-tetrafluoroethane (HCFC-124). Joint Assess. Commod. Chem. 46:1–52.
   Google Scholar
• ECETOC. (2005). 1,1-Dichloro-2,2,2-trifluoroethane (HCFC-123). Joint Assess. Commod. Chem. 47:1–101.
   Google Scholar
• ECETOC. (2006). 1,1,1,2-Tetrafluoroethane (HFC-134a). Joint Assess. Commod. Chem. 50:1–79.
   Google Scholar
• C. Edling, C. G. Ohlson, G. Ljungkvist, A. Oliv, and B. Söderholm. (1990). Cardiac arrhythmia in refrigerator repairmen exposed to fluorocarbons. Br. J. Ind. Med. 47:207–212.
   PubMedGoogle Scholar
• G. M. Egeland, T. F. Bloom, T. M. Schnorr, R. W. Hornung, A. J. Suruda, and K. K. Wille. (1992). Fluorocarbon 113 exposure and cardiac dysrhythmias among aerospace workers. Am. J. Ind. Med. 22:851–857.
   PubMed Web of Science ®Google Scholar
• J. R. Elliott, A. A. Elliott, A. A. Harper, and J. P. Winpenny. (1992). Effects of general anaesthetics on neuronal sodium and potassium channels. Gen. Pharmacol. 23:1005–1011.
   PubMedGoogle Scholar
• M. K. Ellis, R. Trebilcock, J. L. Naylor, K. Tseung, M. A. Collins, P. M. Hext, and T. Green. (1996). The inhalation toxicology, genetic toxicology, and metabolism of difluoromethane in the rat. Fundam. Appl. Toxicol. 31:243–251.
   PubMedGoogle Scholar
• E. A. El-Maghrabi, R. G. Eckenhoff, and H. Shuman. (1992). Saturable binding of halothane to rat brain synaptosomes. Proc. Natl. Acad. Sci. USA 89:4329–4332.
   PubMedGoogle Scholar
• H. H. Emmen, E. M.G, Hoogendijk, W. A.A. Klöpping-Ketelaars, H. Muijser, E. Duistermaat, J. C. Ravensberg, D. J. Alexander, D. Borkhataria, G. M. Rusch, and B. Schmit. (2000). Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a° (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3,3-heptafluoropropane) following whole-body exposure. Regul. Toxicol. Pharmacol. 32:22–35.
   PubMed Web of Science ®Google Scholar
• G. L. Engel. (1971). Sudden and rapid death during psychological stress. Folklore or folk wisdom?. Ann. Int. Med. 74:771–782.
   PubMed Web of Science ®Google Scholar
• H. Eskinder, N. J. Rusch, F. D. Supan, J. P. Kampine, and Z. J. Bosnjak. (1991). The effect of volatile anesthetics on L- and T-type calcium channel currents in canine cardiac Purkinje cells. Anesthesiology 74:919–926.
   PubMedGoogle Scholar
• H. Eskinder, F. D. Supan, L. A. Turner, J. P. Kampine, and Z. J. Bosnjak. (1993). The effects of halothane and isoflurane on slowly inactivating sodium current in canine cardiac Purkinje cells. Anesth. Analg. 77:32–37.
   PubMedGoogle Scholar
• M. D. Esler, M. Alvarenga, G. Lambert, D. Kaye, J. Hastings, G. Jennings, M. Morris, R. Schwarz, and J. Richards. (2004). Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder. Ann. NY Acad. Sci. 1018:505–514.
   PubMed Web of Science ®Google Scholar
• M. Esler, M. Alvarenga, C. Pier, J. Richards, A. El-Osta, D. Barton, D. Haikerwal, D. Kaye, M. Schlaich, L. Guo, G. Jennings, F. Socratous, and G. Lambert. (2006). The neuronal noradrenaline transporter, anxiety and cardiovascular disease. J. Psychopharmacol. 20 (suppl):60–66.
   PubMedGoogle Scholar
• N. A. Estes, H. Garan, and J. N. Ruskin. (1984). Electrophysiologic properties of flecainide acetate. Am. J. Cardiol. 53:26B–29B.
   PubMed Web of Science ®Google Scholar
• L. Fei, J. S. Gill, W. J. McKenna, and J. Camm. (1993). Effects of propafenone on calcium currents in single ventricular myocytes of guinea-pig. Br. J. Pharmacol. 109:178–182.
   PubMed Web of Science ®Google Scholar
• R. J. Flanagan, M. Ruprah, T. J. Meredith, and J. D. Ramsey. (1990). An introduction to the clinical toxicology of volatile substances. Drug Safety 5:359–383.
   PubMed Web of Science ®Google Scholar
• C. H. Follmer, and T. J. Colatsky. (1990). Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes. Circulation 82:289–293.
   PubMed Web of Science ®Google Scholar
• C. H. Follmer, C. A. Cullinan, and T. J. Colatsky. (1992). Differential block of cardiac delayed rectifier current by class Ic antiarrhythmic drugs: Evidence for open channel block and unblock. Cardiovasc. Res. 26:1121–1130.
   PubMedGoogle Scholar
• N. P. Franks, and W. R. Lieb. (1984). Do general anaesthetics act by competitive binding to specific receptors?. Nature 310:599–601.
   PubMed Web of Science ®Google Scholar
• N. P. Franks, and W. R. Lieb. (1988). Volatile general anesthetics activate a novel neuronal K+ current. Nature 333:662–664.
   PubMedGoogle Scholar
• N. P. Franks, and W. R. Lieb. (1991). Stereospecific effects of inhalational general anesthetic optical isomers on nerve ion channels. Science 254:427–430.
   PubMed Web of Science ®Google Scholar
• N P Franks, and W. R. Lieb. (1993). Selective actions of volatile general anaesthetics at molecular and cellular levels. Br. J. Anaesth. 71:65–76.
   PubMed Web of Science ®Google Scholar
• N. P. Franks, and W. R. Lieb. (1994). Molecular and cellular mechanisms of general anaesthesia. Nature 367:607–614.
   PubMed Web of Science ®Google Scholar
• L. C. Freeman, and W. W. Muir. (1991a). Effects of halothane on impulse propagation in Purkinje fibers and at Purkinje–muscle junctions: Relationship of Vmax to conduction velocity. Anesth. Analg. 72:5–10.
   PubMedGoogle Scholar
• L. C. Freeman, and W. W. Muir. (1991b). α -Adrenoceptor stimulation in the presence of halothane: effects on impulse propagation in cardiac Purkinje fibers. Anesth. Analg. 72:11–17.
   PubMedGoogle Scholar
• H. Fujikawa, Y. Sato, H. Arakawa, T. Mitsuhashi, K. Minezaki, S. Kuroki, H. Sekiguchi, T. Nakayama, U. Ikeda, and K. Shimada. (1998). Induction of Torsades de Pointes by dobutamine infusion in a patient with idiopathic long QT syndrome. Int. Med. 37:149–152.
   PubMedGoogle Scholar
• H. Fujita, T. Ogura, M. Tamagawa, H. Uemura, T. Sato, A. Ishida, M. Imamaki, F. Kimura, M. Miyazaki, and H. Nakaya. (2006). A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane. Br. J. Pharmacol. 149:573–580.
   PubMedGoogle Scholar
• C. Funck-Brentano, H. K. Kroemer, J. T. Lee, and D. M. Roden. (1990). Propafenone. N. Engl. J. Med. 322:518–525.
   PubMed Web of Science ®Google Scholar
• J. D. Gallagher, S. N. Weindling, G. Anderson, and M. P. Fillinger. (1998). Effects of sevoflurane on QT interval in a patient with congenital long QT syndrome. Anesthesiology 89:1569–1573.
   PubMed Web of Science ®Google Scholar
• R. S. Gomez, and C. Guatimosim. (2003). Mechanism of action of volatile anesthetics: Involvement of intracellular calcium signaling. Curr. Drug Targets CNS Neurol. Disord. 2:123–129.
   PubMedGoogle Scholar
• A. O. Grant, and J. Tranquillo. (2007). Action potential and QT prolongation not sufficient to cause Torsades de Pointes: Role of action potential triangulation. J. Cardiovasc. Electrophysiol. 18:204–205.
   PubMed Web of Science ®Google Scholar
• A. Groppi, A. Polettini, P. Lunetta, G. Achille, and M. Montagna. (1994). A fatal case of trichlorofluoromethane (Freon 11) poisoning. Tissue distribution study by gas chromatography-mass spectrometry. J. Forens. Sci. 39:871–876.
   PubMedGoogle Scholar
• M. Gruss, T. J. Bushell, D. P. Bright, W. R. Lieb, A. Mathie, and N. P. Franks. (2004). Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol. Pharmacol. 65:443–452.
   PubMed Web of Science ®Google Scholar
• S. Gunnare, L. Ernstgard, B. Sjögren, and G. Johanson. (2006). Toxicokinetics of 1,1,1,2-tetrafluoroethane (HFC–134a) in male volunteers after experimental exposure. Toxicol. Lett. 167:54–65.
   PubMed Web of Science ®Google Scholar
• D. Guo, X. J. Zhao, Y. Wu, T. X. Liu, P. R. Kowey, and G. X. Yan. (2007). L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation. J. Cardiovasc. Electrophysiol. 18:196–203.
   PubMed Web of Science ®Google Scholar
• R. L. Hamlin, C. A. Cruze, S. W. Mittelstadt, A. Kijtawornrat, B. W. Keene, B. M. Roche, T. Nakayama, H. Nakayama, D. M. Hamlin, and T. Arnold. (2004). Sensitivity and specificity of isolated perfused guinea-pig heart to test for drug-induced lengthening of QTc. J. Pharmacol. Toxicol. Methods 49:15–23.
   PubMedGoogle Scholar
• J. C. Hancox, and J. S. Mitcheson. (1997). Inhibition of L-type calcium current by propafenone in single myocytes isolated from the rabbit atrioventricular node. Br. J. Pharmacol. 121:7–14.
   PubMed Web of Science ®Google Scholar
• P. Hantson, O. Vandenplas, A. Dive, and P. Mahieu. (1990). Trichloroethylene and cardiac toxicity: report of two consecutive cases. Acta Clin. Belg. 45:34–37.
   PubMed Web of Science ®Google Scholar
• Goodman & Gilman's The Pharmacological Basis of Therapeutics J. G. Hardman, A. Goodman-Gilman, and L. E. Limbird. McGraw-Hill, New York, (1995).
   Google Scholar
• D. W. Harron, and R. N. Brogden. (1987). Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs 34:617–647.
   PubMedGoogle Scholar
• K. Hashimoto, and K. Hashimoto. (1972). The mechanism of sensitization of the ventricle to epinephrine by halothane. Am. Heart J. 83:652–658.
   PubMedGoogle Scholar
• Y. Hayashi, K. Sumikawa, A. Yamatodani, C. Tashiro, H. Wada, and I. Yoshiya. (1989). Myocardial sensitization by thiopental to arrhythmogenic action of epinephrine in dogs. Anesthesiology 71:929–935.
   PubMedGoogle Scholar
• Y. Hayashi, K. Sumikawa, A. Yamatodani, T. Kamibayashi, M. Kuro, and I. Yoshiya. (1991). Myocardial epinephrine sensitization with subanesthetic concentrations of halothane in dogs. Anesthesiology 74:134–137.
   PubMedGoogle Scholar
• A. R. Hede, B. C. Berglund, and C. Post. (1987). Trichloroethylene and halothane inhibit uptake and metabolism of 5-hydroxytryptamine in rat lung slices. Pharmacol. Toxicol. 61:191–194.
   PubMedGoogle Scholar
• A. R. Hede, and C. Post. (1982). Trichloroethylene and halothane inhibit uptake of 5-hydroxytryptamine in the isolated perfused rat lung. Biochem. Pharmacol. 31:353–358.
   PubMed Web of Science ®Google Scholar
• K. J. Hellestrand, R. S. Bexton, A. W. Nathan, R. A. Spurrell, and A. J. Camm. (1982). Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man. Br. Heart J. 48:140–148.
   PubMedGoogle Scholar
• J. Hescheler, M. Halbach, U. Egert, Z. J. Lu, H. Bohlen, B. K. Fleischmann, and M. Reppel. (2004). Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs. J. Electrocardiol. 37 (suppl):110–116.
   PubMedGoogle Scholar
• C. Heurteaux, N. Guy, C. Laigle, N. Blondeau, F. Duprat, M. Mazzuca, L. Lang-Lazdunski, C. Widmann, M. Zanzouri, G. Romey, and M. Lazdunski. (2004). TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J. 23:2684–2695.
   PubMedGoogle Scholar
• J. T.Y. Hii, G. Wyse, A. M. Gillis, J. M. Cohen, and L. B. Mitchell. (1991). Propafenone-induced Torsades de Pointes: Cross-reactivity with quinidine. Pacing Clin. Electrophysiol. 14:1568–1570.
   PubMedGoogle Scholar
• K. Hirota, Y. Ito, S. Kuze, and Y. Momose. (1992). Effects of halothane on electrophysiologic properties and cyclic adenosine 3′,5′-monophosphate content in isolated guinea-pig hearts. Anesth. Analg. 74:564–569.
   PubMedGoogle Scholar
• K. Hirota, Y. Ito, A. Masuda, and Y. Momose. (1989). Effects of halothane on membrane ionic currents in guinea-pig atrial and ventricular myocytes. Acta Anaesthesiol. Scand. 33:239–244.
   PubMedGoogle Scholar
• L. M. Hondeghem. (2007). Relative contributions of TRIaD and QT to proarrhythmia. J. Cardiovasc. Electrophysiol. 18:655–657.
   PubMed Web of Science ®Google Scholar
• L. M. Hondeghem, and P. Hoffmann. (2003). Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: Importance of triangulation, reverse use-dependence, and instability. J. Cardiovasc. Pharmacol. 41:14–24.
   PubMed Web of Science ®Google Scholar
• L. M. Hondeghem, H. R. Lu, K. van Rossem, and F. De Clerck. (2003). Detection of proarrhythmia in the female rabbit heart: Blinded validation. J. Cardiovasc. Electrophysiol. 14:287–294.
   PubMed Web of Science ®Google Scholar
• H. Honjo, T. Watanabe, K. Kamiya, I. Kodama, and J. Toyama. (1989). Effects of propafenone on electrical and mechanical activities of single ventricular myocytes isolated from guinea-pig hearts. Br. J. Pharmacol. 97:731–738.
   PubMedGoogle Scholar
• R. Hüneke, J. Fassl, R. Rossaint, and A. Lückhof. (2004). Effects of volatile anesthetics on cardiac ion channels. Acta Anaesthesiol. Scand. 48:547–561.
   PubMedGoogle Scholar
• ICH, and ICH guideline S7B (CPMP/ICH/423/02). The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. (2005) http://www.emea.europa.eu/pdfs/human/ich/042302en.pdf.
   Google Scholar
• Y. Ikemoto, A. Yatani, Y. Imoto, and H. Arimura. (1986). Reduction in the myocardial sodium current by halothane and thiamylal. Jpn. J. Physiol. 36:107–121.
   PubMedGoogle Scholar
• Z. Jiao, V. R. de Jesus, S. Iravanian, D. P. Campbell, J. Xu, J. A. Vitali, K. Banach, J. Fahrenbach, and S. C. Dudley. (2006). A possible mechanism of halocarbon-induced cardiac sensitization arrhythmias. J. Mol. Cell. Cardiol. 41:698–705.
   PubMed Web of Science ®Google Scholar
• J. S. Johansson. (1998). Fatal intoxication with 1,1-dichloro = 1-fluoroethane. N. Engl. J. Med. 338:201–202.
   PubMedGoogle Scholar
• R. R. Johnston, E. I. Eger, and C. Wilson. (1976). A comparative interaction of epinephrine with enflurane, isoflurane, and halothane in man. Anesth. Analg. 55:709–712.
   PubMedGoogle Scholar
• P. M. Joksovic, D. A. Bayliss, and S. M. Todorovic. (2005). Different kinetic properties of two T-type Ca2 + currents of rat reticular thalamic neurones and their modulation by ebflurane. J. Physiol. (Lond.) 566:125–142.
   Google Scholar
• R. Jurd, M. Arras, S. Lambert, B. Drexler, R. Siegwart, F. Crestani, M. Zaugg, K. E. Vogt, B. Ledermann, B. Antkowiak, and U. Rudolph. (2003). General anesthetic actions in-vivo strongly attenuated by a point mutation in the GABAA receptor β 3 subunit. FASEB J. 17:250–252.
   PubMedGoogle Scholar
• G. L. Kamatchi, M. E. Durieux, and C. Lynch. (2001). Differential sensitivity of expressed L-type calcium channels and muscarinic M1 receptors to volatile anesthetics in Xenopus oocytes. J. Pharmacol. Exp. Ther. 297:981–990.
   PubMedGoogle Scholar
• K. Kameyama, K. Aono, and K. Kitamura. (1999). Isoflurane inhibits neuronal Ca2 + channels through enhancement of current inactivation. Br. J. Anaesth. 82:402–411.
   PubMedGoogle Scholar
• K. Kamiya, R. Kannan, A. Matin-Asgari, and B. N. Singh. (1989). Electrophysiologic effects of flecainide relative to serum and tissue concentrations in rabbits after chronic drug administration. J. Cardiovasc. Pharmacol. 14:25–30.
   PubMedGoogle Scholar
• J. Kang, W. P. Reynolds, X. L. Chen, J. Ji, H. Wang, and D. E. Rampe. (2006). Mechanisms underlying the QT interval-prolonging effects of sevoflurane and its interactions with other QT-prolonging drugs. Anesthesiology 104:1015–1022.
   PubMedGoogle Scholar
• H. S. Karagueuzian, T. Fujimoto, T. Katoh, T. Peter, A. McCullen, and W. J. Mandel. (1982). Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine. Circulation 66:1190–1198.
   PubMedGoogle Scholar
• A. N. Katchman, J. Koerner, T. Tosaka, R. L. Woosley, and S. N. Ebert. (2006). Comparative evaluation of hERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs. J. Pharmacol. Exp. Ther. 316:1098–106.
   PubMed Web of Science ®Google Scholar
• D. Katritsis, E. Rowland, S. O'Nunain, C. F. Shakespeare, J. Poloniecki, and A. J. Camm. (1995). Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms. Eur. Heart J. 16:1930–1935.
   PubMedGoogle Scholar
• R. L. Katz, and G. J. Katz. (1966). Surgical infiltration of pressor drugs and their interaction with volatile anaesthetics. Br. J. Anaesth. 38:712–718.
   PubMedGoogle Scholar
• J. D. Kaufman, M. S. Morgan, M. L. Marks, H. L. Greene, and L. Rosenstock. (1992). A study of the cardiac effects of bromochlorodifluoromethane (halon 1211) exposure during exercise. Am. J. Ind. Med. 21:223–233.
   PubMedGoogle Scholar
• J. D. Kaufman, M. A. Silverstein, and R. Moure-Eraso. (1994). Atrial fibrillation and sudden death related to occupational solvent exposure. Am. J. Ind. Med. 25:731–735.
   PubMed Web of Science ®Google Scholar
• I. Kawachi, G. A. Colditz, A. Ascherio, E. B. Rimm, E. Giovannucci, M. J. Stampfer, and W. C. Willett. (1994a). Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 89:1992–1997.
   PubMed Web of Science ®Google Scholar
• I. Kawachi, D. Sparrow, P. S. Vokonas, and S. T. Weiss. (1994b). Symptoms of anxiety and risk of coronary heart disease. The normative aging study. Circulation 90:2225–2229.
   PubMed Web of Science ®Google Scholar
• T. Kawano, H. J. Trochimowicz, G. Malinverno, and G. M. Rusch. (1995). Toxicological evaluation of 1,1,1,2,2-pentafluoroethane (HFC–125). Fundam. Appl. Toxicol. 28:223–231.
   PubMedGoogle Scholar
• K. Keller, G. Meyer-Estorf, O. A. Beck, and H. Hochrein. (1978). Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone. Eur. J. Clin. Pharmacol. 13:17–20.
   Google Scholar
• G. S. King, J. E. Smialek, and W. G. Troutman. (1985). Sudden death in adolescents resulting from the inhalation of typewriter correction fluid. J. Am. Med. Assoc. 253:1604–1606.
   PubMed Web of Science ®Google Scholar
• A. Kitamura, W. Marszalec, J. Z. Yeh, and T. Narahashi. (2003). Effects of halothane and propofol on excitatory and inhibitory synaptic transmission in rat cortical neurons. J. Pharmacol. Exp. Ther. 304:162–171.
   PubMedGoogle Scholar
• M. Kohlhardt, and C. Seifert. (1980). Inhibition of Vmax of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardium. Naunyn-Schmiedeberg's Arch. Pharmacol. 315:55–62.
   Google Scholar
• H. Konietzko, and I. Elster. (1973). Toxic effects on heart of trichloroethylene. Arch. Toxikol. 31:93–98.
   PubMedGoogle Scholar
• A. Koreeda, K. Yonemitsu, S. Mimasaka, Y. Ohtsu, and S. Tsunenari. (2007). An accidental death due to Freon 22 (monochlorodifluoromethane) inhalation in a fishing vessel. Forens. Sci. Int. 168:208–211.
   PubMedGoogle Scholar
• M. D. Krasowski, and N. L. Harrison. (1999). General anaesthetic actions on ligand-gated ion channels. Cell. Mol. Life Sci. 55:1278–1303.
   PubMed Web of Science ®Google Scholar
• T. Kubota, and A. Miyata. (2005). Acute inhalational exposure to chlorodifluoromethane (Freon-22): A report of 43 cases. Clin. Toxicol. 43:305–308.
   Web of Science ®Google Scholar
• E. Kuenszberg, A. Loeckinger, A. Kleinsasser, K. H. Lindner, F. Puehringer, and C. Hoermann. (2000). Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. Eur. J. Anaesthesiol. 17:662–664.
   PubMed Web of Science ®Google Scholar
• A. H. Kulier, L. A. Turner, S. Vodanovic, S. Contney, D. A. Lathrop, and Z. J. Bosnjak. (2000). Multiple agents potentiate α1-adrenoceptor-induced conduction depression in canine cardiac Purkinje fibers. Anesthesiology 92:1713–1721.
   PubMed Web of Science ®Google Scholar
• C. W. Lam, F. W. Weir, K. Williams-Cavender, M. N. Tan, T. J. Galen, and D. L. Pierson. (1993). Toxicokinetics of inhaled bromotrifluoromethane (halon 1301) in human subjects. Fundam. Appl. Toxicol. 20:231–239.
   PubMedGoogle Scholar
• Y. Lerman, E. Winkler, M. S. Tirosh, Y. Danon, and S. Almog. (1991). Fatal accidental inhalation of bromochlorodifluoromethane (halon 1211). Hum. Exp. Toxicol. 10:125–128.
   PubMedGoogle Scholar
• F. Lesage. (2003). Pharmacology of neuronal background potassium channels. Neuropharmacology 44:1–7.
   Google Scholar
• Y. Lessard, J. J. Callec, and G. Paulet. (1980). Action du difluorodichloromethane (FC-12) sur l'activite electrique cardiaque de mammifere au niveau cellulaire. C. R. Seances Soc. Biol. Fil. 174:52–57.
   PubMedGoogle Scholar
• Y. Lessard, S. Desbrousses, and G. Paulet. (1977). Arythmie cardiaque chez le chien sous l'action de l'adrenaline et du difluorodichloromethane (FC-12). C. R. Seances Soc. Biol. Fil. 171:1270–1282.
   PubMedGoogle Scholar
• Y. Lessard, and G. Paulet. (1985). Mechanism of liposoluble drugs and general anesthetics membrane action: Action of difluorodichloromethane (FC-12) on different types of cardiac fibers isolated from sheep hearts. Cardiovasc. Res. 19:465–473.
   PubMedGoogle Scholar
• Y. Lessard, and G. Paulet. (1986). A proposed mechanism for cardiac sensitization: Electrophysiological study of effects of difluorodichloromethane and adrenaline on different types of cardiac preparations isolated from sheep hearts. Cardiovasc. Res. 20:807–815.
   PubMed Web of Science ®Google Scholar
• A. M. Linden, M. I. Aller, E. Leppä, O. Vekovischeva, T. Aitta-aho, M. L. Veale, A. Mathie, P. Rosenberg, W. Wisden, and E. R. Korpi. (2006). The in-vivo contributions of TASK-1-containing channels to the actions of inhalation anesthetics, the α2 adrenergic sedative dexmedetomidine, and cannabinoid agonists. J. Pharmacol. Exp. Ther. 317:615–626.
   PubMedGoogle Scholar
• R. Lingamaneni, and H. C. Hemmings. (2003). Differential interaction of anaesthetics and antiepileptic drugs with neuronal Na+ channels, Ca2 + channels, and GABAA receptors. Br. J. Anaesth. 90:199–211.
   PubMedGoogle Scholar
• B. Lown, and M. Wolf. (1971). Approaches to sudden death from coronary heart disease. Circulation 44:130–142.
   PubMed Web of Science ®Google Scholar
• H. K. Lui, G. Lee, P. Dietrich, R. I. Low, and D. T. Mason. (1982). Flecainide-induced QT prolongation and ventricular tachycardia. Am. Heart J. 103:567–569.
   PubMedGoogle Scholar
• G. S. Lysko, J. L. Robinson, R. Casto, and R. A. Ferrone. (1994). The stereospecific effects of isoflurane isomers in-vivo. Eur. J. Pharmacol. 263:25–29.
   PubMed Web of Science ®Google Scholar
• G. Malfatto, A. Zaza, M. Forster, B. Sodowick, P. Danilo, and M. R. Rosen. (1988). Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone. J. Pharmacol. Exp. Ther. 246:419–426.
   PubMed Web of Science ®Google Scholar
• M. Maze, and C. M. Smith. (1983). Identification of receptor mechanism mediating epinephrine-induced arrhythmias during halothane anesthesia in the dog. Anesthesiology 59:322–326.
   PubMed Web of Science ®Google Scholar
• T. S. McDowell, J. J. Pancrazio, P. Q. Barrett, and C. Lynch. (1999). Volatile anesthetic sensitivity of T-type calcium currents in various cell types. Anesth. Analg. 88:168–173.
   PubMedGoogle Scholar
• J. Mergenthaler, W. Haverkamp, A. Hüttenhofer, B. V. Skryabin, U. Musshoff, M. Borggrefe, E. J. Speckmann, G. Breithardt, and M. Madeja. (2001). Blocking effects of the antiarrhythmic drug propafenone on the hERG potassium channel. Naunyn-Schmiedeberg's Arch. Pharmacol. 363:472–480.
   Google Scholar
• S. Metz, and M. Maze. (1985). Halothane concentration does not alter the threshold for epinephrine-induced arrhythmias in dogs. Anesthesiology 62:470–474.
   PubMedGoogle Scholar
• T. Meyer, K. H. Boven, E. Günther, and M. Fejtl. (2004). Micro-electrode arrays in cardiac safety pharmacology. A novel tool to study QT interval prolongation. Drug Safety 27:763–772.
   PubMed Web of Science ®Google Scholar
• S. J. Mihic, Q. Ye, M. J. Wick, V. V. Koltchine, M. D. Krasowski, S. E. Finn, M. P. Mascia, C. F. Valenzuela, K. K. Hanson, E. P. Greenblatt, R. A. Harris, and N. L. Harrison. (1997). Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors. Nature 389:385–389.
   PubMed Web of Science ®Google Scholar
• P. Milberg, E. Hilker, S. Ramtin, Y. Cakir, J. Stypmann, M. A. Engelen, G. Mönnig, N. Osada, G. Breithardt, W. Haverkamp, and L. Eckardt. (2007). Proarrhythmia as a class effect of quinolones: Increased dispersion of repolarization and triangulation of action potential predict Torsades de Pointes. J. Cardiovasc. Electrophysiol. 18:647–654.
   PubMed Web of Science ®Google Scholar
• D. J. Miletich, A. Khan, R. F. Albrecht, and A. Jozefiak. (1983). Use of heart cell cultures as a tool for the evaluation of halothane arrhythmia. Toxicol. Appl. Pharmacol. 70:181–187.
   PubMedGoogle Scholar
• U. Mohamed, C. Napolitano, and S. G. Priori. (2007). Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J. Cardiovasc. Electrophysiol. 18:791–797.
   PubMed Web of Science ®Google Scholar
• M. A. Moore, R. B. Weiskopf, E. I. Eger, and C. Wilson. (1993). Arrhythmogenic doses of epinephrine are similar during desflurane or isoflurane anesthesia in humans. Anesthesiology 79:943–947.
   PubMedGoogle Scholar
• L. S. Mullin, C. F. Reinhardt, and R. E. Hemingway. (1979). Cardiac arrhythmias and blood levels associated with inhalation of Halon 1301. Am. Ind. Hyg. Assoc. J. 40:653–658.
   PubMed Web of Science ®Google Scholar
• H. Naito, and C. N. Gillis. (1968). Anesthetics and response of atria to sympathetic nerve stimulation. Anesthesiology 29:259–266.
   PubMedGoogle Scholar
• S. Nakao, H. Hirata, and Y. Kagawa. (1989). Effects of volatile anesthetics on cardiac calcium channels. Acta Anaesthesiol. Scand. 33:326–330.
   PubMedGoogle Scholar
• A. W. Nathan, K. J. Hellestrand, R. S. Bexton, R. A. Spurrell, and A. J. Camm. (1985). The proarrhythmic effects of flecainide. Drugs 29 (Suppl. 4):45–53.
   PubMedGoogle Scholar
• S. Nattel, and L. Carlsson. (2006). Innovative approaches to anti-arrhythmic drug therapy. Nat. Rev. Drug Discov. 5:1034–1049.
   PubMed Web of Science ®Google Scholar
• R. Navarro, R. B. Weiskopf, M. A. Moore, S. Lockhart, E. I. Eger, D. Koblin, G. Lu, and C. Wilson. (1994). Humans anesthetized with sevoflurane or isoflurane have similar arrhythmic response to epinephrine. Anesthesiology 80:545–549.
   PubMedGoogle Scholar
• S. H. Ngai, P. M. Diaz, and S. Ozer. (1969). The uptake and release of norepinephrine: Effects of cyclopropane and halothane. Anesthesiology 31:45–52.
   PubMedGoogle Scholar
• E. Niggli, A. Rüdisüli, P. Maurer, and R. Weingart. (1989). Effects of general anesthetics on current flow across membranes in guinea-pig myocytes. Am. J. Physiol. 256:C273–C281.
   Google Scholar
• I. M. Nikoronov, T. J.J. Blanck, and E. Recio-Pinto. (1998). The effects of halothane on single human neuronal L-type calcium channels. Anesth. Analg. 86:885–895.
   PubMedGoogle Scholar
• M. Okuda, I. Kunitsugu, S. Kobayakawa, and T. Hobara. (2001). Inhibitory effect of 1,1,1-trichloroethane on calcium channels of neurons. J. Toxicol. Sci. 26:169–176.
   PubMedGoogle Scholar
• M. Otsuka. (1958). Die Wirkung von Adrenalin auf Purkinje-Fasern von Säugetierherzen. Pfluegers Arch. 266:512–517.
   PubMedGoogle Scholar
• J. J. Pancrazio. (1996). Halothane and isoflurane preferentially depress a slowly inactivating component of Ca2 + channel current in guinea-pig myocytes. J. Physiol. (Lond.) 494:91–103.
   Google Scholar
• A. J. Patel, E. Honore, F. Lesage, M. Fink, G. Romey, and M. Lazdunski. (1999). Inhalational anesthetics activate two-pore-domain background K+ channels. Nat/Neurosci. 2:422–426.
   PubMed Web of Science ®Google Scholar
• M. K. Patel, D. Mistry, J. E. JohnIII, and J. P. Mounsey. (2000). Sodium channel isoform-specific effects of halothane: Protein kinase C coexpression and slow inactivation gating. Br. J. Pharmacol. 130:1785–1792.
   PubMedGoogle Scholar
• A. A. Paul, H. J. Witchel, and J. C. Hancox. (2002). Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine. Br. J. Pharmacol. 136:717–729.
   PubMed Web of Science ®Google Scholar
• G. Paulet, and Y. Lessard. (1975). The effect of difluorodichloromethane (FC-12) on isolated rat and rabbit heart. C. R. Seances Soc. Biol. Fil. 169:1048–1053.
   PubMedGoogle Scholar
• F. Pillekamp, M. Reppel, K. Brockmeier, and J. Hescheler. (2006). Impulse propagation in late-stage embryonic and neonatal murine ventricular slices. J. Electrocardiol. 39:425.e1–425.e4.
   Google Scholar
• S. G. Priori, and P. B. Corr. (1990). Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Am. J. Physiol. 258:H1796–H1805.
   PubMed Web of Science ®Google Scholar
• R. M. Puttick, and D. A. Terrar. (1992). Effects of propofol and enflurane on action potentials, membrane currents and contration of guinea-pig isolated ventricular myocytes. Br. J. Pharmacol. 107:559–565.
   PubMedGoogle Scholar
• K. S. Ramos, E. Chacon, and D. Acosta. Toxic responses of the heart and vascular systemCasarett & Doull's Toxicology. The Basic Science of Poisons C. D. Klaassen. McGraw-Hill, New York, (1996) 487–527.
   Google Scholar
• L. Ratnakumari, and H. C. Hemmings. (1998). Inhibition of presynaptic sodium channels by halothane. Anesthesiology 88:1043–1054.
   PubMedGoogle Scholar
• L. Ratnakumari, T. N. Vysotskaya, D. S. Duch, and H. C. Hemmings. (2000). Differential effects of anesthetic and non-anesthetic cyclobutanes on neuronal voltage-gated sodium channels. Anesthesiology 92:529–541.
   PubMedGoogle Scholar
• W. S. Redfern, L. Carlsson, A. S. Davis, W. G. Lynch, I. MacKenzie, S. Palethorpe, P. K. Siegl, I. Strang, A. T. Sullivan, R. Wallis, A. J. Camm, and T. G. Hammond. (2003). Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58:32–45.
   PubMed Web of Science ®Google Scholar
• N. Rehnqvist, C. G. Ericsson, S. Eriksson, G. Olsson, and G. Svensson. (1984). Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction. Acta Med. Scand. 216:525–530.
   PubMedGoogle Scholar
• C. F. Reinhardt, A. Azar, M. E. Maxfield, P. E. Smith, and L. S. Mullin. (1971). Cardiac arrhythmias and aerosol “sniffing”. Arch. Environ. Health 22:265–279.
   PubMed Web of Science ®Google Scholar
• M. Reppel, P. Igelmund, U. Egert, F. Juchelka, J. Hescheler, and I. Drobschinskaya. (2007). Effect of cardioactive drugs on action potential generation and propagation in embryonic stem cell-derived cardiomyocytes. Cell. Physiol. Biochem. 19:213–224.
   PubMed Web of Science ®Google Scholar
• A. K. Reynolds. (1984). On the mechanism of myocardial sensitization to catecholamines by hydrocarbon anesthetics. Can. J. Physiol. Pharmacol. 62:183–198.
   PubMedGoogle Scholar
• G. D. Ritchie, E. C. Kimmel, L. E. Bowen, J. E. Reboulet, and J. Rossi. (2001). Acute neurobehavioral effects in rats from exposure to HFC 134a or CFC 12. NeuroToxicology 22:233–248.
   PubMed Web of Science ®Google Scholar
• A. Rithalia, P. M. Hopkins, and S. M. Harrison. (2004). The effects of halothane, isoflurane, and sevoflurane on Ca2 + current and transient outward K+ current in subendocardial and subepicardial myocytes from the rat left ventricle. Anesth. Analg. 99:1615–1622.
   PubMedGoogle Scholar
• D. M. Roden, J. R. Balser, A. L. George, and M. E. Anderson. (2002). Cardiac ion channels. Annu. Rev. Physiol. 64:431–475.
   PubMed Web of Science ®Google Scholar
• M. Rodstein, L. Wolloch, and R. S. Gubner. (1971). Mortality study of the significance of extrasystoles in an insured population. Circulation 44:617–625.
   PubMed Web of Science ®Google Scholar
• M. Rosengarten, and R. Brooks. (1987). Torsade de pointes ventricular tachycardia in a hypothyroid patient treated with propafenone. Can. J. Cardiol. 3:234–239.
   PubMedGoogle Scholar
• U. Rudolph, and B. Antkowiak. (2004). Molecular and neuronal substrates for general anaesthetics. Nature Rev. Neurosci. 5:709–720.
   PubMed Web of Science ®Google Scholar
• U. Rudolph, and H. Möhler. (2004). Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu. Rev. Pharmacol. Toxicol. 44:475–498.
   PubMed Web of Science ®Google Scholar
• M. Sakata, H. Kazama, A. Miki, A. Yoshida, M. Haga, and M. Morita. (1981). Acute toxicity of fluorocarbon-22: Toxic symptoms, lethal concentration, and its fate in rabbit and mouse. Toxicol. Appl. Pharmacol. 59:64–70.
   PubMed Web of Science ®Google Scholar
• M. A. Samuels. (2007). The brain–heart connection. Circulation 116:77–84.
   PubMed Web of Science ®Google Scholar
• B. Sarubbi, V. Ducceschi, N. Briglia, R. Esposito, M. S. Mayer, A. Scialdone, L. Santangelo, and A. Iacono. (1996). Sotalol, propafenone, and flecainide: Compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy. Cardiologia 41:645–651.
   PubMedGoogle Scholar
• B. Sarubbi, V. Ducceschi, N. Briglia, M. S. Mayer, L. Santangelo, and A. Iacono. (1998). Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease. Int. J. Cardiol. 66:157–64.
   PubMedGoogle Scholar
• H. Satoh, and K. Hashimoto. (1984). Effects of propafenone on the membrane currents of rabbit sino-atrial node cells. Eur. J. Pharmacol. 99:185–191.
   PubMedGoogle Scholar
• M. Schlepper. (1987). Propafenone, a review of its profile. Eur. Heart J. 8 (suppl.A):27–32.
   PubMedGoogle Scholar
• M. T. Slawsky, and N. A. Castle. (1994). K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. J. Pharmacol. Exp. Ther. 269:66–74.
   PubMedGoogle Scholar
• W. T. Schmeling, D. C. Warltier, D. J. McDonald, K. E. Madsen, J. L. Atlee, and J. P. Kampine. (1991). Prolongation of the QT interval by enflurane, isoflurane, and halothane in humans. Anesth. Analg. 72:137–144.
   PubMed Web of Science ®Google Scholar
• E. P. Scholz, M. Alter, E. Zitron, C. Kiesecker, S. Kathöfer, D. Thomas, V. A.W. Kreye, J. Kreuzer, R. Becker, H. A. Katus, J. Greten, and C. A. Karle. (2006). In-vitro modulation of hERG channels by organochlorine solvent trichloromethane as potential explanation for proarrhythmic effects of chloroform. Toxicol. Lett. 165:156–166.
   PubMedGoogle Scholar
• T. J. Shafer, P. J. Bushnell, V. A. Benignus, and J. J. Woodward. (2005). Perturbation of voltage-sensitive Ca2 + channel function by volatile organic solvents. J. Pharmacol. Exp. Ther. 315:1109–1118.
   PubMed Web of Science ®Google Scholar
• R. T. Shepherd. (1989). Mechanism of sudden death associated with volatile substance abuse. Hum. Toxicol. 8:287–292.
   PubMedGoogle Scholar
• S. Shibata, K. Ono, and T. Iijima. (2004). Sevoflurane inhibition of the slowly activating delayed rectifier K+ current in guinea-pig ventricular cells. J. Pharmacol. Sci. 95:363–373.
   PubMedGoogle Scholar
• W. J. Shin, and B. D. Winegar. (2003). Modulation of noninactivating K+ channels in rat cerebellar granule neurons by halothane, isoflurane, and sevoflurane. Anesth. Analg. 96:1340–1344.
   PubMedGoogle Scholar
• M. Shiraishi, and R. A. Harris. (2004). Effects of alcohols and anesthetics on recombinant voltage-gated Na+ channels. J. Pharmacol. Exp. Ther. 309:987–994.
   PubMedGoogle Scholar
• J. E. Sirois, Q. Lei, E. M. Talley, C. Lynch, and D. A. Bayliss. (2000). The TASK-1 two-pore domain K+ channel is a molecular substrate for neuronal effects of inhalation anesthetics. J. Neurosci. 20:6347–6354.
   PubMed Web of Science ®Google Scholar
• M. Skrzypiec-Spring, B. Grotthus, A. Szelag, and R. Schulz. (2007). Isolated heart perfusion according to Langendorff—Still viable in the new millenium. J. Pharmacol. Toxicol. Methods 55:113–126.
   PubMedGoogle Scholar
• R. D. Smith, and C. E. Pettway. (1975). Absence of sensitization to epinephrine-induced cardiac arrhythmia and fibrillation in dogs and cats anesthetized with CI-744. Am. J. Vet. Res. 36:695–698.
   PubMedGoogle Scholar
• R. Snyder, K. S. Bakshi, and B. M. Wagner. (1997). Abstracts of the workshop on toxicity of alternatives to chlorofluorocarbons. Inhal. Toxicol. 9:775–810.
   Google Scholar
• J. M. Sonner, J. F. Antognini, R. C. Dutton, P. Flood, A. T. Gray, R. A. Harris, G. E. Homanics, J. Kendig, B. Orser, D. E. Raines, J. Trudell, B. Vissel, and E. I. Eger. (2003). Inhaled anesthetics and immobility: Mechanisms, mysteries, and minimum alveolar anesthetic concentration. Anesth. Analg. 97:718–740.
   PubMedGoogle Scholar
• A. Stadnicka, Z. J. Bosnjak, J. P. Kampine, and W. M. Kwok. (2000). Modulation of cardiac inward rectifier K+ current by halothane and isoflurane. Anesth. Analg. 90:824–833.
   PubMedGoogle Scholar
• A. Stadnicka, W. M. Kwok, H. A. Hartmann, and Z. J. Bosnjak. (1999). Effects of halothane and isoflurane on fast and slow inactivation of human heart hH1a sodium channels. Anesthesiology 90:1671–1683.
   PubMedGoogle Scholar
• E. M. Steidl, E. Neveu, D. Bertrand, and B. Buisson. (2006). The adult rat hippocampal slice revisited with multi-electrode arrays. Brain Res. 1096:70–84.
   PubMedGoogle Scholar
• G. Steinbeck. Tachykarde RhythmusstörungenHerzrhythmusstörungen B. Lüderitz. Springer, Berlin-Heidelberg-, New York, (1983) 617–641.
   Google Scholar
• K. Sumikawa, N. Ishizaka, and M. Suzaki. (1983). Arrhythmogenic plasma levels of epinephrine during halothane, enflurane, and pentobarbital anesthesia in the dog. Anesthesiology 58:322–325.
   PubMed Web of Science ®Google Scholar
• A. Suzuki, Z. J. Bosnjak, and W. M. Kwok. (2003). The effects of isoflurane on the cardiac slowly activating delayed-rectifier potassium channel in guinea-pig ventricular myocytes. Anesth. Analg. 96:1308–1315.
   PubMed Web of Science ®Google Scholar
• A. Takahara, A. Sugiyama, and K. Hashimoto. (2005a). Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation. Br. J. Pharmacol. 146:561–567.
   PubMedGoogle Scholar
• A. Takahara, A. Sugiyama, Y. Satoh, K. Wang, S. Honsho, and K. Hashimoto. (2005b). Halothane sensitizes the canine heart to pharmacological IKr blockade. Eur. J. Pharmacol. 507:169–177.
   PubMedGoogle Scholar
• H. Takahashi, R. M. Puttick, and D. A. Terrar. (1994). The effects of propofol and enflurane on single calcium channel currents of guinea-pig isolated ventricular myocytes. Br. J. Pharmacol. 111:1147–1153.
   PubMedGoogle Scholar
• M. Takenoshita, and J. H. Steinbach. (1991). Halothane blocks low-voltage-activated calcium current in rat sensory neurons. J. Neurosci. 11:1404–1412.
   Google Scholar
• P. W.L. Tas, H. G. Kress, and K. Koschel. (1987). Volatile anesthetics and n-alkanols inhibit the uptake of noradrenaline into pheochromocytoma cells. Anaesthesist 36:340–344.
   PubMedGoogle Scholar
• H. E.D.J. Ter Keurs, and P. A. Boyden. (2007). Calcium and arrhythmogenesis. Physiol. Rev. 87:457–506.
   PubMed Web of Science ®Google Scholar
• D. A. Terrar, and J. G. Victory. (1988). Influence of halothane on electrical coupling in cell pairs isolated from guinea-pig ventricle. Br. J. Pharmacol. 94:509–514.
   PubMedGoogle Scholar
• C. Terrenoire, I. Lauritzen, F. Lesage, G. Romey, and M. Lazdunski. (2001). A TREK–1-like potassium channel in atrial cells inhibited by β -adrenergic stimulation and activated by volatile anesthetics. Circ. Res. 89:336–342.
   PubMed Web of Science ®Google Scholar
• C. Terrenoire, V. Piriou, R. Bonvallet, C. Chouabe, L. Espinosa, O. Rougier, and Y. Tourneur. (2000). Opposite effects of halothane on guinea-pig ventricular action potential duration. Eur. J. Pharmacol. 390:95–101.
   PubMedGoogle Scholar
• J. Thevenin, A. Da Costa, F. Roche, C. Romeyer, M. Messier, and K. Isaaz. (2003). Flecainide induced ventricular tachycardia (torsades de pointes). Pacing Clin. Electrophysiol. 26:1907–1908.
   PubMed Web of Science ®Google Scholar
• E. B. Thompson, and F. T. Galysh. (1973). Quantitative assessment of anesthetic-induced cardiac sensitization to epinephrine. Anesth. Analg. 52:800–806.
   PubMedGoogle Scholar
• K. A. Thompson, D. H.S. Iansmith, L. A. Siddoway, R. L. Woosley, and D. M. Roden. (1988). Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers. J. Pharmacol. Exp. Ther. 244:950–955.
   PubMedGoogle Scholar
• W. J. Tranquilli, J. C. Thurmon, G. J. Benson, and L. E. Davis. (1986). Alteration in the arrhythmogenic dose of epinephrine (ADE) following xylazine administration to halothane-anesthetized dogs. J. Vet. Pharmacol. Ther. 9:198–203.
   PubMedGoogle Scholar
• H. J. Trochimowicz, A. Azar, J. B. Terrill, and L. S. Mullin. (1974). Blood levels of fluorocarbon related to cardiac sensitization: Part II. Am. Ind. Hyg. Assoc. J. 35:632–639.
   PubMed Web of Science ®Google Scholar
• L. A. Turner, J. Marijic, J. P. Kampine, and Z. J. Bosnjak. (1990). A comparison of the effects of halothane and tetrodotoxin on the regional repolarization characteristics of canine Purkinje fibers. Anesthesiology 73:1158–1168.
   PubMedGoogle Scholar
• L. A. Turner, S. Polic, R. G. Hoffmann, J. P. Kampine, and Z. J. Bosnjak. (1993a). Actions of halothane and isoflurane on Purkinje fibers in the infarcted canine heart: Conduction, regional refractoriness, and reentry. Anesth. Analg. 76:718–725.
   PubMedGoogle Scholar
• L. A. Turner, S. Polic, R. G. Hoffmann, J. P. Kampine, and Z. J. Bosnjak. (1993b). Actions of volatile anesthetics on ischemic and nonischemic Purkinje fibers in the infarcted canine heart: Regional action potential characteristics. Anesth. Analg. 76:726–733.
   PubMedGoogle Scholar
• S. Ueno, J. R. Trudell, E. I. Eger, and R. A. Harris. (1999). Actions of fluorinated alkanols on GABAA receptors: Relevance to theories of narcosis. Anesth. Analg. 88:877–883.
   PubMedGoogle Scholar
• J. P. Valentin, P. Hoffmann, F. De Clerck, T. G. Hammond, and L. Hondeghem. (2004). Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs. J. Pharmacol. Toxicol. Methods 49:171–181.
   PubMedGoogle Scholar
• F. Vanhoutte, J. Vereecke, E. Carmeliet, and N. Verbeke. (1991). Effects of the enantiomers of flecainide on action potential characteristics in the guinea-pig papillary muscle. Arch. Int. Pharmacol. Ther. 310:102–114.
   PubMedGoogle Scholar
• C. S. Venugopalan, E. Holmes, and N. A. O'Malley. (1989). Comparison of arrhythmogenic doses of epinephrine in heartworm-infected and noninfected dogs. Am. J. Vet. Res. 50:1872–1876.
   PubMedGoogle Scholar
• A. Vinegar, and G. W. Jepson. (1996). Cardiac sensitization thresholds of halon replacement chemicals predicted in humans by physiologically-based pharmakokinetic modeling. Risk Anal. 16:571–579.
   PubMed Web of Science ®Google Scholar
• A. Vinegar, G. W. Jepson, M. Cisneros, R. Rubinstein, and W. J. Brock. (2000). Setting safe acute exposure limits for halon replacement chemicals using physiologically based pharmacokinetic modeling. Inhal. Toxicol. 12:751–763.
   PubMed Web of Science ®Google Scholar
• S. Vodanovic, L. A. Turner, R. G. Hoffmann, J. P. Kampine, and Z. J. Bosnjak. (1997). Actions of phenylephrine, isoproterenol, and epinephrine with halothane on endocardial conduction and activation in canine left ventricular papillary muscles. Anesthesiology 87:117–126.
   PubMedGoogle Scholar
• M. A. Vos, J. M. van Opstal, J. D.M. Leunissen, and S. C. Verduyn. (2001). Electrophysiologic parameters and predisposing factors in the generation of drug-induced Torsades de Pointes arrhythmias. Pharmacol. Ther. 92:109–122.
   PubMed Web of Science ®Google Scholar
• C. P. Washburn, J. E. Sirois, E. M. Talley, P. G. Guyenet, and D. A. Bayliss. (2002). Serotonergic raphe neurons express TASK channel transcripts and a TASK-like pH- and halothane-sensitive K+ conductance. J. Neurosci. 22:1256–1265.
   PubMedGoogle Scholar
• E. M. Waters, H. B. Gerstner, and J. E. Huff. (1977). Trichloroethylene—An overview. J. Toxicol. Environ. Health 2:671–707.
   PubMed Web of Science ®Google Scholar
• L. G. Weigl, and W. Schreibmayer. (2001). G protein-gated inwardly rectifying potassium channels are targets for volatile anesthetics. Mol. Pharmacol. 60:282–289.
   PubMedGoogle Scholar
• H. U. Weigt, W. M. Kwok, G. C. Rehmert, and Z. J. Bosnjak. (1998a). Modulation of the cardiac sodium current by inhalational anesthetics in the absence and presence of β -stimulation. Anesthesiology 88:114–124.
   PubMedGoogle Scholar
• H. U. Weigt, W. M. Kwok, G. C. Rehmert, and Z. J. Bosnjak. (1998b). Sensitization of the cardiac Na channel to α1-adrenergic stimulation by inhalation anesthetics. Evidence for distinct modulatory pathways. Anesthesiology 88:125–133.
   PubMedGoogle Scholar
• H. U. Weigt, W. M. Kwok, G. C. Rehmert, L. A. Turner, and Z. J. Bosnjak. (1997a). Voltage-dependent effects of volatile anesthetics on cardiac sodium current. Anesth. Analg. 84:285–293.
   PubMedGoogle Scholar
• H. U. Weigt, W. M. Kwok, G. C. Rehmert, L. A. Turner, and Z. J. Bosnjak. (1997b). Modulation of cardiac sodium current by α1-stimulation and volatile anesthetics. Anesthesiology 87:1507–1516.
   PubMedGoogle Scholar
• H. U. Weigt, G. C. Rehmert, Z. J. Bosnijak, and W. M. Kwok. (1997). Conformational state-dependent effects of halothane on cardiac Na+ current. Anesthesiology 87:1494–1506.
   PubMedGoogle Scholar
• J. Weissenburger, V. V. Nesterenko, and C. Antzelevitch. (2000). Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in-vivo: Torsades de Pointes develops with halothane but not pentobarbital anesthesia. J. Cardiovasc. Electrophysiol. 11:290–304.
   PubMed Web of Science ®Google Scholar
• J. F. White, and G. P. Carlson. (1981). Epinephrine-induced cardiac arrhythmias in rabbits exposed to trichloroethylene: Role of trichloroethylene metabolites. Toxicol. Appl. Pharmacol. 60:458–465.
   PubMed Web of Science ®Google Scholar
• F. Wickers, M. Haissaguere, and J. Palussiere. (1988). QT prolongation and induction of torsade de pointe by flecainide. Apropos of a case. Arch. Mal. Coeur Vaiss. 81:1283–1285.
   PubMedGoogle Scholar
• D. J.C. Wilkinson, J. M. Thompson, G. W. Lambert, G. L. Jennings, R. G. Schwarz, D. Jefferys, A. G. Turner, and M. D. Esler. (1998). Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch. Gen. Psychiatry 55:511–520.
   PubMed Web of Science ®Google Scholar
• E. Winslow, and J. K. Campbell. (1991). Comparative frequency-dependent effects of three class Ic agents, ORG 7797, flecainide, and propafenone, on ventricular action potential duration. J. Cardiovasc. Pharmacol. 18:911–917.
   PubMedGoogle Scholar
• H. J. Witchel, C. E. Dempsey, R. B. Sessions, M. Perry, J. T. Milnes, J. C. Hancox, and J. S. Mitcheson. (2004). The low-potency, voltage-dependent hERG blocker propafenone: Molecular determinants and drug trapping. Mol. Pharmacol. 66:1201–1212.
   PubMed Web of Science ®Google Scholar
• A. Woodall, N. Bracken, A. Qureshi, F. C. Howarth, and J. Singh. (2004). Halothane alters contractility and Ca2 + transport in ventricular myocytes from streptozotocin-induced diabetic rats. Mol. Cell. Biochem. 261:251–262.
   PubMed Web of Science ®Google Scholar
• B. H. Woollen, E. A. Guest, W. Howe, J. R. Marsh, H. K. Wilson, T. R. Auton, and P. G. Blain. (1990). Human inhalation pharmacokinetics of 1,1,2-trichloro-1,2,2-trifluoroethane (FC113). Int. Arch. Occup. Environ. Health 62:73–78.
   PubMed Web of Science ®Google Scholar
• B. H. Woollen, J. R. Marsh, J. D. Mahler, T. R. Auton, D. Makepeace, J. Cocker, and P. G. Blain. (1992). Human inhalation pharmacokinetics of chlorodifluoromethane (HCFC22). Int. Arch. Occup. Environ. Health 64:383–387.
   PubMed Web of Science ®Google Scholar
• G. X. Xiang, L. B. Pan, L. Huang, Z. Y. Yu, X. D. Song, J. Cheng, W. Xing, and Y. X. Zhou. (2007). Microelectrode array-based system for neuropharmacological applications with cortical neurons cultured in-vitro. Biosensors Bioelectron. 22:2478–2484.
   PubMedGoogle Scholar
• M. Yamada, N. Hatakeyama, A. P. Malykhina, M. Yamazaki, Y. Momose, and H. I. Akbarali. (2006). The effects of sevoflurane and propofol on QT interval and heterologously expressed human ether-a-go-go-related gene currents in Xenopus oocytes. Anesth. Analg. 102:98–103.
   PubMedGoogle Scholar
• K. Yamamoto, T. Tamura, R. Imai, and M. Yamamoto. (2001). Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation—Influences of anesthesia and validation with quinidine and astemizole. Toxicol. Sci. 60:165–176.
   PubMed Web of Science ®Google Scholar
• C. S. Yost. (2000). Tandem pore domain K channels: An important site of volatile anesthetic action?. Curr. Drug Targets 1:207–217.
   PubMedGoogle Scholar
• C. S. Yost. (2003). Update on tandem pore (2P) domain K+ channels. Curr. Drug Targets 4:347–351.
   PubMedGoogle Scholar
• O. Zolk, and T. Eschenhagen. KardiotoxizitätLehrbuch der Toxikologie H. Marquardt, and S. Schäfer. Wissenschaftliche Verlagsgesellschaft, Stuttgart, (2004) 557–578.
   Google Scholar
• B. N.M. Zordoky, and A. O.S. El-Kadi. (2007). H9c2 cell line is a valuable in-vitro model to study the drug metabolizing enzymes in the heart. J. Pharmacol. Toxicol. Methods 56:317–322.
   PubMedGoogle Scholar